DXPE NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

DXP Enterprises Inc · Industrials · Industrial Distribution

Open interactive chart View report data
Latest close 157.0 USD
-7.1% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 5.2% above the Trend Line and sits at 73.1% of its 52-week range. The latest completed week returned -7.1%, after a -0.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 51/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 57 out of 100
Latest Close 157.0 USD 31 Jul 2026
1W Return -7.1% latest completed week
4W Return -0.6% short-term follow-through
12W Return 0.5% quarterly tape
Trend Breadth 80.8% 42 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 27-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 55.68% based on similar historical setup states.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 11 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.1% Latest completed week; four-week move -0.6%. Indicator stack 89/23 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.68% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 51/100 conviction; expected move 12.7%. News sentiment 54/100 46 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.2% above the Trend Line and sits at 73.1% of its 52-week range. The latest completed week returned -7.1%, after a -0.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7712-week average 0.82

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1111 reversal markers

No recent accumulation markers. 11 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -0.6% over four weeks, 0.5% over 12 weeks, and 42.7% over one year. The current trend has remained active for 27 consecutive weeks.

Performance by holding period

1W-7.1%
4W-0.6%
12W0.5%
26W20.7%
52W42.7%
Active trend streak27 weeks
Active weeks in one year42
Trend breadth80.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.45Latest activity-pressure read.
Pressure change-235.1%Four-week change in activity pressure.
Leadership8.22Latest relative-leadership reading.
RS change15.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value23/100Relative valuation strength. Underlying universe rank 78; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework51/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
29.8x
Price divided by trailing earnings.
Price / sales
1.3x
Market value relative to trailing revenue.
EV / EBITDA
14.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
31.7%
Gross profit retained from each unit of revenue.
Operating margin
8.8%
Operating profit retained from revenue.
Free-cash-flow margin
7.0%
Free cash flow generated from revenue.
Return on invested capital
11.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.5%
Latest one-year revenue growth.
EPS growth
10.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
20.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.7%
Net share repurchases relative to market value.
Shareholder yield
0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

DXPE shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 12.7%, and Sharemaestro trend signal active.

Conviction51/100
Expected move12.7%
Put/call volume0.00
Pressure100
Speculation0
Volatility88
Trend agreement0
Open options detail
Insider activity4 / 15

4 acquisitions and 15 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 46 relevant articles.

12 positive · 28 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move12.7%Nearest-chain priced movement where available.
52-week drawdown-14.6%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+15.0%Week of 6 Feb.
Worst week-7.5%Week of 8 May.
Latest week-7.1%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses7
Sharp losses5
Recent vol5.1%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape60/100

Trend, activity pressure, participation, and risk combine to a 60/100 tape read.

 Indicator analysis67/100

Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 11/12.

Activity pressure 0.77; 11 reversal markers Next-Week ExpectancyPositive 55.68%

Next-week expectancy is positive with a 55.68% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors59/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 34; Small Cap Core rank 82 SVQF51/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 353.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

DXPE shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 12.7%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 12.7% Sentiment54/100

Weighted news tone is neutral across 46 relevant articles.

Arrowstreet Capital Limited Partnership Sells 26,648 Shares of DXP Enterprises, Inc. $DXPE Insiders4 / 15

4 acquisitions and 15 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026157.0 USD-7.1%149.3 USD84.02 USD-0.458.22668.5KOn
24 Jul 2026168.9 USD0.6%147.6 USD83.25 USD-0.2917.38533.1KOn
17 Jul 2026168.0 USD3.3%145.9 USD82.41 USD-0.0515.44502.7KOn
10 Jul 2026162.6 USD2.9%144.0 USD81.58 USD0.187.72748.5KOn
3 Jul 2026158.0 USD-3.3%142.2 USD80.77 USD0.337.13832.5KOn
26 Jun 2026163.4 USD-5.9%140.1 USD80.00 USD0.3612.321.3MOn
19 Jun 2026173.7 USD2.8%137.8 USD79.18 USD0.0214.80651.4KOn
12 Jun 2026168.9 USD7.3%135.0 USD78.30 USD-0.2715.48620.0KOn
5 Jun 2026157.4 USD8.5%132.4 USD77.45 USD-0.3711.03719.9KOn
29 May 2026145.1 USD0.6%130.5 USD76.67 USD-0.17-1.65633.3KOn
22 May 2026144.2 USD-1.8%129.7 USD75.96 USD0.380.95698.9KOn
15 May 2026146.8 USD-6.0%128.9 USD75.24 USD0.894.41960.8KOn
8 May 2026156.2 USD-7.5%127.7 USD74.50 USD1.2011.061.1MOn
1 May 2026168.9 USD-0.4%126.5 USD73.68 USD1.2627.271.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.